semaglutide drug mounjaro FDA approves new version of diabetes for weight loss Australia's drug regulator issues mental

10.1016/S0140-6736(14)60649-8 52 LeeP

In fact, people with diabetes are twice as likely to have heart disease or stroke.[2] The leading cause of morbidity and mortality for individuals with diabetes is atherosclerortic cardiovascular disease (CVD), which includes coronary heart disease, cerebrovascular disease or peripheral arterial disease

These studies also show that Mounjaro may be more effective for helping people with type 2 diabetes lose weight

Further, another inflammatory pathway marker transcription factor, nuclear factor kappa B (NF-B) activity has been shown to be increased in the brains of AD patients (Hong, 2017)

Rossini, P

A gradient-echo EPI sequence, TR = 1000 ms, TE = 13 ms, FOV = 20 7.9 mm 2 , slices: 13, slice thickness = 0.6 mm, matrix size = 121 48, repetitions = 480, was used to obtain resting state functional MRI (rs-fMRI) blood oxygen level-dependent (BOLD) data